title: B-type natriuretic Peptide: application in the community.
abstract: Natriuretic peptide assessment has represented a significant advance in the management of heart failure. In a syndrome in which clinical symptoms and signs can be either nonspecific or absent, the presence of a reliable biomarker to aid diagnosis, assess prognosis, and potentially guide treatment and aid in prevention of this syndrome has represented a significant advance. The following review will outline established and potential new roles for natriuretic peptide assessment in the community.
authors.affiliation: St Vincent's University Hospital, Dublin, Ireland. kenneth.mcdonald@ucd.ie
authors.forename: Ken
authors.initials: K
authors.lastname: McDonald
authors.forename: Ulf
authors.initials: U
authors.lastname: Dahlström
authors.forename: Nadia
authors.initials: N
authors.lastname: Aspromonte
authors.forename: Patrick
authors.initials: P
authors.lastname: Jourdain
authors.forename: Alan
authors.initials: A
authors.lastname: Maisel
authors.forename: Christian
authors.initials: C
authors.lastname: Mueller
authors.forename: Roberto
authors.initials: R
authors.lastname: Valle
mesh_terms: D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D008403:Mass Screening; D020097:Natriuretic Peptide, Brain; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D020097:Natriuretic Peptide, Brain